Spallone V, Ziegler D, Freeman R, Bernardi L, Frontoni S, Pop-Busui R, Stevens M, Kempler P, Hilsted J, Tesfaye S, et al. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev. 2011;27:639–53.

Article  PubMed  Google Scholar 

Williams S, Raheim SA, Khan MI, Rubab U, Kanagala P, Zhao SS, Marshall A, Brown E, Alam U. Cardiac autonomic neuropathy in type 1 and 2 diabetes: epidemiology, pathophysiology, and management. Clin Ther. 2022;44(10):1394–416.

Article  CAS  PubMed  Google Scholar 

Fisher VL, Tahrani AA. Cardiac autonomic neuropathy in patients with diabetes mellitus: current perspectives. Diabetes Metab Syndr Obes. 2017;10:419–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Andersen ST, Witte DR, Fleischer J, Andersen H, Lauritzen T, Jorgensen ME, Jensen TS, Pop-Busui R, Charles M. Risk factors for the presence and progression of cardiovascular autonomic neuropathy in type 2 diabetes: ADDITION-Denmark. Diabetes Care. 2018;41(12):2586–94.

Article  PubMed  Google Scholar 

Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, Sosenko JM, Ziegler D. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40(1):136–54.

Article  CAS  PubMed  Google Scholar 

Stranieri A, Abawajy J, Kelarev A, Huda S, Chowdhury M, Jelinek HF. An approach for Ewing test selection to support the clinical assessment of cardiac autonomic neuropathy. Artif Intell Med. 2013;58(3):185–93.

Article  PubMed  Google Scholar 

Chowdhury M, Nevitt S, Eleftheriadou A, Kanagala P, Esa H, Cuthbertson DJ, Tahrani A, Alam U. Cardiac autonomic neuropathy and risk of cardiovascular disease and mortality in type 1 and type 2 diabetes: a meta-analysis. BMJ Open Diabetes Res Care. 2021;9(2): e002480.

Article  PubMed  PubMed Central  Google Scholar 

Pop-Busui R, Evans GW, Gerstein HC, Fonseca V, Fleg JL, Hoogwerf BJ, Genuth S, Grimm RH, Corson MA, Prineas R, et al. Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care. 2010;33(7):1578–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fang M, Wang D, Coresh J, Selvin E. Trends in Diabetes Treatment and Control in U.S. Adults, 1999–2018. N Engl J Med. 2021;384(23):2219–28.

Article  PubMed  PubMed Central  Google Scholar 

Ford ES. Trends in the control of risk factors for cardiovascular disease among adults with diagnosed diabetes: findings from the National Health and Nutrition Examination Survey 1999–2008*. J Diabetes. 2011;3(4):337–47.

Article  PubMed  Google Scholar 

Davis WA, Gregg EW, Davis TME. Temporal trends in cardiovascular complications in people with or without type 2 diabetes: the Fremantle Diabetes Study. J Clin Endocrinol Metab. 2020;105(7):e2471–82.

Article  Google Scholar 

Gregg EW, Cheng YJ, Srinivasan M, Lin J, Geiss LS, Albright AL, Imperatore G. Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data. Lancet. 2018;391(10138):2430–40.

Article  PubMed  Google Scholar 

Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D, Williams DE, Geiss L. Changes in diabetes-related complications in the United States, 1990–2010. N Engl J Med. 2014;370(16):1514–23.

Article  CAS  PubMed  Google Scholar 

Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62(1):3–16.

Article  PubMed  Google Scholar 

Davis T, Bruce D, Davis W. Cohort profile: the Fremantle Diabetes Study. Int J Epidemiol. 2013;42(2):412–21.

Article  PubMed  Google Scholar 

Socio-economic indexes for areas. http://www.abs.gov.au/websitedbs/censushome.nsf/home/seifa.

Krakauer NY, Krakauer JC. Anthropometrics, metabolic syndrome, and mortality hazard. J Obes. 2018;2018:9241904.

Article  PubMed  PubMed Central  Google Scholar 

Freeman R, Wieling W, Axelrod F, Benditt D, Benarroch E, Biaggioni I, Cheshire W, Chelimsky T, Cortelli P, Gibbons C, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21(2):69–72.

Article  PubMed  Google Scholar 

Pop-Busui R, Backlund JC, Bebu I, Braffett BH, Lorenzi G, White NH, Lachin JM, Soliman EZ, Group DER. Utility of using electrocardiogram measures of heart rate variability as a measure of cardiovascular autonomic neuropathy in type 1 diabetes patients. J Diabetes Investig. 2022;13(1):125–33.

Article  CAS  PubMed  Google Scholar 

Pop-Busui R, Low PA, Waberski BH, Martin CL, Albers JW, Feldman EL, Sommer C, Cleary PA, Lachin JM, Herman WH, et al. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC). Circulation. 2009;119(22):2886–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ewing D, Campbell I, Clarke B. Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications. Ann Intern Med. 1980;92(2_Part_2):308–11.

Article  CAS  PubMed  Google Scholar 

Ziegler D, Laux G, Dannehl K, Spuler M, Muhlen H, Mayer P, Gries F. Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses. Diabetic Med. 1992;9(2):166–75.

Article  CAS  PubMed  Google Scholar 

Gelber DA, Pfeifer M, Dawson B, Schumer M. Cardiovascular autonomic nervous system tests: determination of normative values and effect of confounding variables. J Auton Nerv Syst. 1997;62(1–2):40–4.

Article  CAS  PubMed  Google Scholar 

Risk M, Bril V, Broadbridge C, Cohen A. Heart rate variability measurement in diabetic neuropathy: review of methods. Diabetes Technol Ther. 2001; 3(1):63–76.

Spallone V, Bellavere F, Scionti L, Maule S, Quadri R, Bax G, Melga P, Viviani G, Esposito K, Morganti R, et al. Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy. Nutr Metab Cardiovasc Dis. 2011;21(1):69–78.

Article  CAS  PubMed  Google Scholar 

Levey A, Bosch J, Lewis J, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461–70.

Article  CAS  PubMed  Google Scholar 

Davis WA, Hamilton E, Davis TME. Temporal trends in distal symmetric polyneuropathy in type 2 diabetes: the Fremantle Diabetes Study. J Clin Endocrinol Metab. 2023;109:e1083–94.

Article  PubMed Central  Google Scholar 

Holman C, Bass A, Rouse I, Hobbs M. Population-based linkage of health records in Western Australia: development of a health services research linked database. Aust N Z J Public Health. 1999;23(5):453–9.

Article  CAS  PubMed  Google Scholar 

Vinik A, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007;115(3):387–97.

Article  PubMed  Google Scholar 

Hu MX, Milaneschi Y, Lamers F, Nolte IM, Snieder H, Dolan CV, Penninx B, de Geus EJC. The association of depression and anxiety with cardiac autonomic activity: the role of confounding effects of antidepressants. Depress Anxiety. 2019;36(12):1163–72.

Article  PubMed  PubMed Central  Google Scholar 

Pop-Busui R, Braffett BH, Zinman B, Martin C, White NH, Herman WH, Genuth S, Gubitosi-Klug R, Group DER. Cardiovascular autonomic neuropathy and cardiovascular outcomes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study. Diabetes Care. 2017;40(1):94–100.

Article  Google Scholar 

Young LH, Wackers FJ, Chyun DA, Davey JA, Barrett EJ, Taillefer R, Heller GV, Iskandrian AE, Wittlin SD, Filipchuk N, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA. 2009;301(15):1547–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaze AD, Yuyun MF, Erqou S, Fonarow GC, Echouffo-Tcheugui JB. Cardiac autonomic neuropathy and risk of incident heart failure among adults with type 2 diabetes. Eur J Heart Fail. 2022;24(4):634–41.

Article  PubMed  Google Scholar 

Woods JA, Katzenellenbogen JM, Davidson PM, Thompson SC. Heart failure among Indigenous Australians: a systematic review. BMC Cardiovasc Disord. 2012;12:99.

Article  PubMed  PubMed Central  Google Scholar 

Zhou L, Deng W, Zhou L, Fang P, He D, Zhang W, Liu K, Hu R. Prevalence, incidence and risk factors of chronic heart failure in the type 2 diabetic population: systematic review. Curr Diabetes Rev. 2009;5(3):171–84.

Article  CAS  PubMed  Google Scholar 

Davis TM, McAullay D, Davis WA, Bruce DG. Characteristics and outcome of type 2 diabetes in urban Aboriginal people: the Fremantle Diabetes Study. Intern Med J. 2007;37(1):59–63.

Article  CAS  PubMed  Google Scholar 

Raghavan S, Vassy JL, Ho YL, Song RJ, Gagnon DR, Cho K, Wilson PWF, Phillips LS. Diabetes mellitus-related all-cause and cardiovascular mortality in a national cohort of adults. J Am Heart Assoc. 2019;8(4): e011295.

Article  PubMed  PubMed Central